.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Chubb
Dow
Covington
AstraZeneca
Queensland Health
Cerilliant
McKesson
US Army
UBS

Generated: December 18, 2017

DrugPatentWatch Database Preview

FROVA Drug Profile

« Back to Dashboard

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Endo PharmsFROVAfrovatriptan succinateTABLET;ORAL021006-001Nov 8, 2001ABRXYesYes► Subscribe► Subscribe► Subscribe
Glenmark Pharms LtdFROVATRIPTAN SUCCINATEfrovatriptan succinateTABLET;ORAL204730-001Mar 11, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Pharms IncFROVATRIPTAN SUCCINATEfrovatriptan succinateTABLET;ORAL202931-001Aug 28, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: FROVA

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Endo PharmsFROVAfrovatriptan succinateTABLET;ORAL021006-001Nov 8, 2001► Subscribe► Subscribe
Endo PharmsFROVAfrovatriptan succinateTABLET;ORAL021006-001Nov 8, 2001► Subscribe► Subscribe
Endo PharmsFROVAfrovatriptan succinateTABLET;ORAL021006-001Nov 8, 2001► Subscribe► Subscribe
Endo PharmsFROVAfrovatriptan succinateTABLET;ORAL021006-001Nov 8, 2001► Subscribe► Subscribe
Endo PharmsFROVAfrovatriptan succinateTABLET;ORAL021006-001Nov 8, 2001► Subscribe► Subscribe
Endo PharmsFROVAfrovatriptan succinateTABLET;ORAL021006-001Nov 8, 2001► Subscribe► Subscribe
Endo PharmsFROVAfrovatriptan succinateTABLET;ORAL021006-001Nov 8, 2001► Subscribe► Subscribe
Endo PharmsFROVAfrovatriptan succinateTABLET;ORAL021006-001Nov 8, 2001► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV (Patent) Challenges for FROVA

Drugname Dosage Strength RLD Submissiondate
frovatriptan succinateTablets2.5 mgFrova3/9/2011

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
Novartis
Queensland Health
Moodys
Daiichi Sankyo
Merck
Dow
Baxter
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot